Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS.
暂无分享,去创建一个
D. Dieterich | J. Orenstein | D. Kotler | M. Poles | E. Lew | Douglas T. Dieterich | J. M. Orenstein | Edward A. Lew | D. P. Kotler
[1] D. Leroy,et al. IFN-gamma involvement in the severity of gram-negative infections in mice. , 1993, Journal of immunology.
[2] M. Glauser,et al. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. , 1993, The Journal of infectious diseases.
[3] R. Ulevitch,et al. Purification and characterization of murine lipopolysaccharide-binding protein , 1993, Infection and immunity.
[4] P. Elsbach,et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide , 1992, Infection and immunity.
[5] R. Ulevitch,et al. Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS‐binding protein , 1992, Journal of leukocyte biology.
[6] J. Cohen,et al. Differential effects of monoclonal antibodies to tumor necrosis factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram-negative sepsis , 1992, Infection and immunity.
[7] C. Nathan,et al. Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] H. Langstein,et al. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. , 1992, Journal of immunology.
[9] Richard Graham Knowles,et al. Enhancers of nonspecific immunity induce nitric oxide synthase: Induction does not correlate with toxicity or adjuvancy , 1992, European journal of immunology.
[10] P. Elsbach,et al. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. , 1992, The Journal of clinical investigation.
[11] R. Ulevitch,et al. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. , 1992, Journal of immunology.
[12] R. Ulevitch,et al. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. , 1992, Journal of immunology.
[13] P. Abbet,et al. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. , 1992, Journal of immunology.
[14] M. N. Marra,et al. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. , 1992, Journal of immunology.
[15] S. Corradin,et al. Phagocytosis enhances murine macrophage activation by interferon‐γ and tumor necrosis factor‐α , 1991 .
[16] M. Glauser,et al. Septic shock: pathogenesis , 1991, The Lancet.
[17] M. Doerfler,et al. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils , 1991, The Journal of experimental medicine.
[18] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[19] Y. Buchmüller‐Rouiller,et al. Journal of Leukocyte Biology 49:73-82 (1991) Killing of Leishmania Parasites in Activated Murine Macrophages is Based on an L-Arginine-Dependent Process That Produces Nitrogen Derivatives , 2022 .
[20] F. Liew,et al. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. , 1990, Journal of immunology.
[21] R. Ulevitch,et al. Structure and function of lipopolysaccharide binding protein. , 1990, Science.
[22] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[23] M. N. Marra,et al. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. , 1990, Journal of immunology.
[24] M. Meltzer,et al. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. , 1990, Journal of immunology.
[25] R. Ulevitch,et al. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. , 1989, The Journal of biological chemistry.
[26] C. E. Ooi,et al. Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. , 1989, The Journal of biological chemistry.
[27] P. Elsbach,et al. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. , 1989, Journal of immunology.
[28] C. Nathan,et al. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.
[29] R. Ulevitch,et al. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. , 1988, The Journal of biological chemistry.
[30] M. Marletta,et al. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. , 1987, Journal of immunology.
[31] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[32] R. Ulevitch,et al. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.
[33] J. Mauël. Intracellular parasite killing induced by electron carriers. I. Effect of electron carriers on intracellular Leishmania spp. in macrophages from different genetic backgrounds. , 1984 .
[34] A. Kelso,et al. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. , 1982, Journal of immunology.
[35] S. Russell,et al. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. , 1981, Journal of immunology.
[36] H. Odeberg,et al. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. , 1978, The Journal of biological chemistry.
[37] K. Tracey,et al. The role of cytokine mediators in septic shock. , 1990, Advances in surgery.
[38] A. Billiau. Gamma-interferon: the match that lights the fire? , 1988, Immunology today.
[39] H. Büller,et al. Endotoxemia, bacteremia and urosepsis. , 1988, Progress in clinical and biological research.
[40] Y. Buchmüller‐Rouiller,et al. Effect of lipopolysaccharide on intracellular killing of Leishmania enriettii and correlation with macrophage oxidative metabolism , 1987, European journal of immunology.
[41] M. Meltzer,et al. Activation of macrophages to kill rickettsiae and Leishmania: dissociation of intracellular microbicidal activities and extracellular destruction of neoplastic and helminth targets. , 1984, Contemporary topics in immunobiology.
[42] D. Morrison,et al. Bacterial endotoxins and host immune responses. , 1979, Advances in immunology.